MET overexpression as a hallmark of the epithelial-mesenchymal transition (EMT) phenotype in colorectal cancer

被引：0
|
作者：
Raghav, Kanwal Pratap Singh [1 ]
Wang, Wenting [1 ]
Overman, Michael J. [1 ]
Kopetz, Scott [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.334
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MET overexpression as a hallmark of the epithelial-mesenchymal transition (EMT) phenotype in colorectal cancer.
    Raghav, Kanwal Pratap Singh
    Amin, Hesham M.
    Wang, Wenting
    Manyam, Ganiraju C.
    Broom, Bradley
    Eng, Cathy
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] The epithelial-mesenchymal transition (EMT) and colorectal cancer progression
    Bates, RC
    Mercurio, AM
    CANCER BIOLOGY & THERAPY, 2005, 4 (04) : 365 - 370
  • [3] Epithelial-mesenchymal transition (EMT) in vulvar cancer
    Horn, L. C.
    Eckey, C.
    Hiller, R. G. G.
    Hoeckel, M.
    Kruecken, I
    Obeck, U.
    Stiller, M.
    Hoehn, K. A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : E30 - E30
  • [4] Adipokines and epithelial-mesenchymal transition (EMT) in cancer
    Ioanna Akrida
    Helen Papadaki
    Molecular and Cellular Biochemistry, 2023, 478 : 2419 - 2433
  • [5] Adipokines and epithelial-mesenchymal transition (EMT) in cancer
    Akrida, Ioanna
    Papadaki, Helen
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (11) : 2419 - 2433
  • [6] Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer
    Odero-Marah, Valerie
    Hawsawi, Ohuod
    Henderson, Veronica
    Sweeney, Janae
    CELL & MOLECULAR BIOLOGY OF PROSTATE CANCER: UPDATES, INSIGHTS AND NEW FRONTIERS, 2018, 1095 : 101 - 110
  • [7] Epithelial-Mesenchymal Transition (EMT)
    Manfioletti, Guidalberto
    Fedele, Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [8] Colorectal cancer progression -: Integrin αvβ6 and the epithelial-mesenchymal transition (EMT)
    Bates, RC
    CELL CYCLE, 2005, 4 (10) : 1350 - 1352
  • [9] Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states
    Yoshida, T.
    Ozawa, Y.
    Kimura, T.
    Sato, Y.
    Kuznetsov, G.
    Xu, S.
    Uesugi, M.
    Agoulnik, S.
    Taylor, N.
    Funahashi, Y.
    Matsui, J.
    BRITISH JOURNAL OF CANCER, 2014, 110 (06) : 1497 - 1505
  • [10] Therapeutic implications of cancer epithelial-mesenchymal transition (EMT)
    Cho, Eunae Sandra
    Kang, Hee Eun
    Kim, Nam Hee
    Yook, Jong In
    ARCHIVES OF PHARMACAL RESEARCH, 2019, 42 (01) : 14 - 24
12345